secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q32 Bio Inc. (QTTB)
CIK:        0001661998
Form:       8-K
Filed at:   2022-03-16T23:59:59+00:00
Accession:  0001193125-22-077227
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Homology closes $130M AAV manufacturing JV with Oxford; retains 20% stake plus put/call option
--------------------------------------------------------------------------------

- Homology transferred AAV manufacturing assets to Newco for 175,000 units, then sold 130,000 units to OXB for $130M cash.
- OXB contributed $50M for 50,000 units; post-closing OXB owns 80%, Homology owns 20% of Newco.
- After three years, Homology can put (or OXB can call) Homology's Newco stake at 5.5x trailing revenue, subject to cap.
- Pro forma shows estimated gain of $145M on derecognition of assets and equity method investment of $45M as of Sept 30, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661998/000119312522077227/0001193125-22-077227-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661998/000119312522077227/d327212d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-077227

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer